Wu Shuang, Li Tianye, Liu Weiwei, Huang Yongye
College of Life and Health Sciences, Northeastern University, Shenyang, China.
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Jilin University, Changchun, China.
Front Cell Dev Biol. 2021 Sep 8;9:733751. doi: 10.3389/fcell.2021.733751. eCollection 2021.
Cell death induction has become popular as a novel cancer treatment. Ferroptosis, a newly discovered form of cell death, features regulated, iron-dependent accumulation of lipid hydroperoxides. Since this word "ferroptosis" was coined, numerous studies have examined the complex relationship between ferroptosis and cancer. Here, starting from the intrinsic hallmarks of cancer and cell death, we discuss the theoretical basis of cell death induction as a cancer treatment. We review various aspects of the relationship between ferroptosis and cancer, including the genetic basis, epigenetic modification, cancer stem cells, and the tumor microenvironment, to provide information and support for further research on ferroptosis. We also note that exosomes can be applied in ferroptosis-based therapy. These extracellular vesicles can deliver different molecules to modulate cancer cells and cell death pathways. Using exosomes to control ferroptosis occurring in targeted cells is promising for cancer therapy.
诱导细胞死亡已成为一种新型癌症治疗方法。铁死亡是一种新发现的细胞死亡形式,其特征是脂质氢过氧化物的调节性铁依赖性积累。自“铁死亡”一词被创造以来,大量研究探讨了铁死亡与癌症之间的复杂关系。在此,我们从癌症和细胞死亡的内在特征出发,讨论诱导细胞死亡作为癌症治疗方法的理论基础。我们综述了铁死亡与癌症关系的各个方面,包括遗传基础、表观遗传修饰、癌症干细胞和肿瘤微环境,为进一步研究铁死亡提供信息和支持。我们还指出,外泌体可应用于基于铁死亡的治疗。这些细胞外囊泡可以递送不同分子来调节癌细胞和细胞死亡途径。利用外泌体控制靶向细胞中的铁死亡在癌症治疗中具有广阔前景。